Merck Research Laboratories - Comment

Document ID: FDA-2011-D-0620-0006
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: November 18 2011, at 12:00 AM Eastern Standard Time
Date Posted: December 22 2011, at 12:00 AM Eastern Standard Time
Comment Start Date: September 19 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: November 18 2011, at 11:59 PM Eastern Standard Time
Tracking Number: 80f6f797
View Document:  View as format xml

View Comment

See attached file(s)

Attachments:

Merck Research Laboratories Comment Letter 2011-D-0620 DGFI Self Section -final 11182011

Title:
Merck Research Laboratories Comment Letter 2011-D-0620 DGFI Self Section -final 11182011

View Attachment: View as format pdf

Related Comments

   
Total: 4
Eric Paul Brass - Comment
Public Submission    Posted: 11/14/2011     ID: FDA-2011-D-0620-0003

Nov 18,2011 11:59 PM ET
Merck Research Laboratories - Comment
Public Submission    Posted: 12/22/2011     ID: FDA-2011-D-0620-0006

Nov 18,2011 11:59 PM ET
GlaxoSmithKline Consumer Healthcare - Comment
Public Submission    Posted: 12/22/2011     ID: FDA-2011-D-0620-0007

Nov 18,2011 11:59 PM ET
Consumer Healthcare Products Association (CHPA) - Comment
Public Submission    Posted: 12/22/2011     ID: FDA-2011-D-0620-0004

Nov 18,2011 11:59 PM ET